BUFFALO, N.Y., Oct. 17 (UPI) -- The U.S. National Institutes of Health announced a two-year study of abnormal iron metabolism that is linked with several neurodegenerative disorders.
Professor Daniel Kosman of the University at Buffalo's School of Medicine and Biomedical Sciences received a $418,363 NIH grant to search for ways to keep iron levels in balance in the neurodegenerative disease called aceruloplasminemia and to develop drugs to correct imbalances.
The research complements the $1.1 million, four-year NIH grant Kosman received in June to study how iron is metabolized in cells.
The research will be conducted in collaboration with Dr. Zena Leah Harris, a specialist in pediatric clinical care at Johns Hopkins University's School of Medicine, and Dr. Jonathan Gitlin, a professor of pediatrics and genetics at the Washington University School of Medicine.
